Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Long-Term Debt Issuances (2020 - 2025)

Historic Long-Term Debt Issuances for Vistagen Therapeutics (VTGN) over the last 6 years, with Q2 2025 value amounting to $1.0 million.

  • Vistagen Therapeutics' Long-Term Debt Issuances changed N/A to $1.0 million in Q2 2025 from the same period last year, while for Dec 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $224400.0 for FY2021, which is N/A changed from last year.
  • Latest data reveals that Vistagen Therapeutics reported Long-Term Debt Issuances of $1.0 million as of Q2 2025.
  • Over the past 5 years, Vistagen Therapeutics' Long-Term Debt Issuances peaked at $1.0 million during Q2 2025, and registered a low of $1.0 million during Q2 2025.